Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.
Vermeire S, Sands BE, Peyrin-Biroulet L, D'Haens GR, Panés J, Yarur AJ, Wolf DC, Ritter T, Schreiber S, Woolcott JC, Modesto I, Keating M, Shan K, Wu J, Chiorean MV, Baert F, Dubinsky MC, Goetsch M, Danese S, Feagan BG.
Vermeire S, et al. Among authors: sands be.
J Crohns Colitis. 2024 Jun 15:jjae079. doi: 10.1093/ecco-jcc/jjae079. Online ahead of print.
J Crohns Colitis. 2024.
PMID: 38877972